The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fibroblast growth factor receptor status and response to immune checkpoint inhibition in metastatic urothelial cancer.
 
Tracy L Rose
Research Funding - Bristol-Myers Squibb; GeneCentric; Roche/Genentech; X4 Pharma
 
Michele C Hayward
No Relationships to Disclose
 
Ashley H Salazar
Research Funding - GeneCentric
 
Patrick Eulitt
No Relationships to Disclose
 
Katrina McGinty
No Relationships to Disclose
 
Anthony Drier
No Relationships to Disclose
 
Sara Elizabeth Wobker
Research Funding - GeneCentric
 
Young E. Whang
Research Funding - Astellas Pharma (Inst); Clovis Oncology (Inst); Innocrin Pharma (Inst); Inovio Pharmaceuticals (Inst)
 
Blaine Y Brower
No Relationships to Disclose
 
Mary Dunn
No Relationships to Disclose
 
Daniel James Crona
No Relationships to Disclose
 
Yoichiro Shibata
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - Patent pending for Tumor Mutation Burden (TMB) from RNA-seq
 
Joshua M Uronis
No Relationships to Disclose
 
Gregory Mayhew
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - I hold no patents. But just in case want to say I've signed legal documents for the company I am employed by (GeneCentric Therapeutics) transferring patent rights associated with inventions I've worked on to the company.
Travel, Accommodations, Expenses - GeneCentric
 
Matthew I. Milowsky
Consulting or Advisory Role - BioClin Therapeutics
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
William Y. Kim
Stock and Other Ownership Interests - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb; FibroGen; G1 Therapeutics; G1 Therapeutics; Johnson & Johnson; Kura Oncology; Spectrum Pharmaceuticals
Honoraria - Takeda
Consulting or Advisory Role - Foundation Medicine; GeneCentric
Research Funding - Foundation Medicine; GeneCentric; Merck
Patents, Royalties, Other Intellectual Property - BASE47 bladder cancer subtype classifier
Travel, Accommodations, Expenses - Takeda